Mary Burns, MD
Urogynecology and Reconstructive Pelvic Surgery · Viriginia Beach, VANPI 1437181484
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,726 of the $5,744 with a category attached, or 64.9%. 14 manufacturers reported payments, led by Intuitive Surgical at 46.4% of the total. Reporting peaked in 2019 at $3,372 and has fallen 83.3% since, to $562 in 2025.
Across 78 payments — averaging $73.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- Medtronic$2K
- AbbVie$337
- Axonics, Inc.$263
- Astellas Pharma US Inc$142
- Daiichi Sankyo Inc.$125
- plus $553 from 8 others
Across 1 payment — averaging $551.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$551
What the payments were for
- Travel & lodging$3,72665%
- Food & beverage$2,01835%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 19 | $2,668 |
| Medtronic(2 entities) | 35 | $1,656 |
| AbbVie | 3 | $337 |
| Axonics, Inc. | 3 | $263 |
| Astellas Pharma US Inc | 2 | $142 |
| Daiichi Sankyo Inc. | 1 | $125 |
| AMAG Pharmaceuticals, Inc. | 1 | $122 |
| Myovant Sciences Inc. | 1 | $118 |
| Coloplast | 3 | $91 |
| Minerva Surgical, Inc | 6 | $83 |
| Coopersurgical, Inc. | 1 | $70 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Laborie Medical Technologies Corp. | 1 | $23 |
| Boston Scientific | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$2,408
- INTERSTIM$958
- Orilissa$337
- INJECTAFER$125
- Veozah$125
- INTRAROSA$122
- MYFEMBREE$118
- Bulkamid$108
How this compares
$5,744 in reported general payments places this provider in the 70th percentile of 29 urogynecology and reconstructive pelvic surgery providers in Virginia.
See all urogynecology and reconstructive pelvic surgery providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 23 | $20,067 |
| MyrbetriqMirabegron | 16 | $16,290 |
| Estradiol | 108 | $7,694 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 65 | $1,178 |
| Oxybutynin Chloride ErOxybutynin Chloride | 20 | $642 |
| Fluconazole | 25 | $170 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 27 | $60 |
| Oxycodone Hcl | 23 | $42 |
| Ibuprofen | 19 | $30 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $25 | $20,06723 claims |
| Astellas Pharma US IncMyrbetriq | $142 | $16,29016 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 29 urogynecology and reconstructive pelvic surgery providers in Virginia.
Other urogynecology and reconstructive pelvic surgery in Viriginia Beach
- Seyed ShobeiriFalls Church$116K
- Kurt McCammonVirginia Beach$67K
- Jeffrey WelgossAnnandale$50K
- Nathan GueretteMidlothian$20K
- Eric ChangStafford$11K
- Patricia MwesigwaArlington$8K
- Anna TrikhachevaPortsmouth$6K
- Walter von PechmannAnnandale$6K
- Meghana GowdaRichmond$5K
- Nina DereskaRoanoke$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.